In 2024, doctors and parents scrambled to find an affordable asthma inhaler after drugmaker GSK pulled the popular Flovent ...
A Somerset woman says she suffered a severe asthma attack after having her prescription changed without consultation. Sue* ...
Umeclidinium-vilanterol is associated with improved clinical outcomes in symptomatic patients with chronic obstructive pulmonary disease.
Positive and clinically meaningful results from the Phase III KALOS and LOGOS trials for BREZTRIin patients with uncontrolled asthma published in The Lancet Respiratory Medicine Full results from the ...
Asthma affects one in nine Australians, resulting in about 32,000 mostly avoidable hospitalisations a year, and more than 400 deaths. As we face the challenges of bushfires, abrupt weather changes and ...
Adults with mild-to-moderate asthma who take regular inhaled corticosteroids can achieve greater control of airway inflammation by also using the 2-in-1 combination budesonide-formoterol as a reliever ...
People prescribed beclometasone inhalers are encouraged to read up on the NHS guidelines for the drug. The inhalers are often prescribed for people with asthma, and sometimes for other respiratory ...
Individuals relying on beclometasone inhalers for asthma or related respiratory ailments may wish to familiarise themselves with NHS recommendations surrounding this treatment. These steroid-based ...
As new trial findings show significant reductions in paediatric asthma attacks from a budesonide-formoterol 2-in-1 reliever therapy, Professor Andy Bush speaks to Saša Janković about the system ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results